The Latest

  • A person places a pulse oximeter clip on another person's finger.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips wins FDA clearance for new pulse oximeter

    Philips said its updated device provides accurate readings across a range of skin tones, following concerns that pulse oximeters can be less accurate in people with darker skin pigmentation.

    Updated 21 hours ago
    FDA
  • Two people in suits shake hands.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Cardinal inks 2 acquisitions in bid to expand at-home services

    The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.

    M&A
  • A person wearing a blue glove holds a test tube with red liquid
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Tempus to buy cancer test maker Personalis for $1.5B

    Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

    M&A
  • A person stands in front of the screen of a machine on wheels, near a sign that says "GE HealthCare"
    Image attribution tooltip
    Stringer via Getty Images
    Image attribution tooltip

    GE HealthCare inks 10-year, $500M alliance with Catholic Health

    The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and UC San Diego.

  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Resmed ventilator safety issue linked to 5 serious injuries

    The supply of the circuit boards needed to fix the devices is significantly constrained, preventing the company from immediately correcting all affected ventilators.

    FDA
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott discloses cyberattack on cancer diagnostics business

    The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of information was accessed.

  • A clinician wearing blue scrubs and a mask stands near a da Vinci 5 robotic system in an operating room.
    Image attribution tooltip
    Permission granted by Staten Island University Hospital
    Image attribution tooltip

    Intuitive ties Q2 procedure softness to ACA subsidy expirations

    Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.

  • A modern two-story commercial office building with a mix of gray and wood paneling on the exterior. Large glass windows dominate both floors, and the front entrance features the "Medtronic" logo above double glass doors. The surrounding area includes a few small shrubs and empty parking spaces in front.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtronic completes SPR Therapeutics acquisition

    Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.

    M&A
  • A stethoscope rests on a pile of $100 bills.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Large funding rounds help boost digital health investment in H1

    Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.

  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip
    Q&A

    Abbott’s cancer diagnostics vision: ‘There’s always a hunger to make these tests better’

    Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, discusses the future of the field.

  • Three gray, rectangular devices are pictured next to each other.
    Image attribution tooltip
    Courtesy of Expanding Innovations
    Image attribution tooltip

    DePuy Synthes adds spine implants with Expanding Innovations buy

    DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys portfolio.

    M&A
  • Senior Research Associate Tanya Quint loads one of the instruments used to run Exact Sciences' Cologuard test at the company's headquarters in Madison, Wis. (Photo: Business Wire)
    Image attribution tooltip
    Courtesy of Exact Sciences/Business Wire
    Image attribution tooltip

    Abbott reports diagnostics growth since $21B Exact Sciences buy

    The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.

  • A view of Vicarious Surgical's robot in development.
    Image attribution tooltip
    Courtesy of Vicarious Surgical
    Image attribution tooltip

    Vicarious Surgical board proposes dissolving the company

    The robot developer’s board set a July 21 date for shareholders to vote on a proposal to wind down operations amid expectations for continued operating losses.

  • A sign for Zimmer Biomet is shown outside of the company's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer Biomet names new Asia Pacific president

    Chintan Desai, formerly of Alcon and GE HealthCare, has experience leading medtech teams in the region.

  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J misses company expectations for cardiovascular in Q2

    Sales in Johnson & Johnson’s Abiomed business declined in the second quarter due to procedure volume pressures related to its Impella device.

  • The SS Innovations SSi Mantra robotic system.
    Image attribution tooltip
    Permission granted by SS Innovations
    Image attribution tooltip

    SS Innovations names Sarah Romano as CFO

    Romano, who is joining from rival robotic surgery company Vicarious Surgical, will step into a position that has been held by a series of executives over the past year.

  • One of the entrances to the Federal Trade Commission Building in Washington, DC, that serves as the headquarters of the Federal Trade Commission (FTC).
    Image attribution tooltip
    hapabapa via Getty Images
    Image attribution tooltip

    Edwards will pay $10M to settle FTC charges of skirting antitrust review

    The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to sidestep a Hart-Scott-Rodino review.

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic recalls heart valve delivery catheter for risk of tip detaching

    Certain delivery systems that are used to insert a pulmonary valve have an increased risk of distal tip detachment, the company said. The valve itself is not affected by the recall.

  • Histosonics' Edison histotripsy system is pictured in an operating room.
    Image attribution tooltip
    Permission granted by Histosonics
    Image attribution tooltip

    HistoSonics wins Europe’s CE mark for histotripsy system

    HistoSonics’ phased commercial rollout of the Edison system will initially target centers specializing in liver tumor treatment.

  • An illustration of pain in the colon.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Freenome colorectal cancer test data improve on earlier results

    The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.

  • A patient recovers after a total knee replacement surgery.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Whoop tests wearable platform in joint replacement recovery

    The program, a partnership with Kinomatic, will use biometric data and care coordination between visits to support recovery after surgery.

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Top medtech executive moves in 2026

    Medtronic created a new position, while Illumina built out its C-suite and DePuy Synthes named its CFO ahead of a split with J&J. Read MedTech Dive’s roundup for all the details.

    Updated July 13, 2026
    M&A
  • The entrance to Illumina's San Diego campus.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    Illumina builds out C-suite with 2 new execs

    The gene sequencing company this week named a new chief commercial officer and chief legal officer.

  • An image of a robotic surgery system.
    Image attribution tooltip
    Courtesy of Medicaroid
    Image attribution tooltip

    Medicaroid wins Europe’s CE mark for Hinotori surgical robot

    The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after expanding in the Asia-Pacific region.

  • An image of a robotic surgery system.
    Image attribution tooltip
    Permission granted by Stereotaxis
    Image attribution tooltip

    Stereotaxis closes Robocath takeover

    With the acquisition of Robocath completed, Stereotaxis intends to accelerate development of next-generation robotic technologies for endovascular procedures.

    M&A